9-Methoxy-1,2,3,4-tetrahydropyrazino[1,2-a]indole, 97%, 100mg

(E)-(2-Nitrovinyl)benzene, 98.0%, 25g

4-(6-Methoxy-2-methylsulfanyl-pyrimidin-4-ylamino)-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 100mg

1'-(TERT-BUTOXYCARBONYL)SPIRO[CHROMAN-4,4'-PIPERIDINE]-2-CARBOXYLIC ACID, 95.0%, 1g

1,4-Diazabicyclo [2.2.2] octane, 99.0%, 1kg

Methyl 4-bromothiophene-2-carboxylate, 95.0%, 250g

4-BROMO-2-FLUOROPYRIDINE-3-CARBOXYLIC ACID, 95.0%, 250mg

4-Amino-1-(1-Boc-pyrrolidin-3-yl)-1H-pyrazole, 97.0%, 25g

Ethyl Butyrate>98.0%(GC)500mL

4,4-Dimethyl-2-phenyl-4,5-dihydrooxazole, 96%, 1g

3-Amino-4-hydroxybenzohydrazide, 98%, 250mg

N-Methylhex-5-en-1-amine hydrochloride, 95.0%, 100mg

GC capillary column ROTI®Cap-5, 25 m, 0.53 mm, 5.00 µm, 1 Piece(s)